Trending

Emcure Pharma Review: Jefferies, Kotak Maintain Buy; Raise Growth Estimates

NDTV - Trending·4 Nov 2026
Emcure Pharma Review: Jefferies, Kotak Maintain Buy; Raise Growth Estimates

Emcure Pharmaceuticals' Q2 performance and improving growth outlook have prompted Jefferies and Kotak to maintain their Buy ratings.

More news in Trending